Abstract:Spinal cord injury (SCI) and spinal infarction lead to neurological complications and eventually to paraplegia or quadriplegia. These extremely debilitating conditions are major contributors to morbidity. Our understanding of SCI has certainly increased during the last decade, but remains far from clear. SCI consists of two defined phases: the initial impact causes primary injury, which is followed by a prolonged secondary injury consisting of evolving sub-phases that may last for years. The underlying pathophysiological mechanisms driving this condition are complex. Derangement of the vasculature is a notable feature of the pathology of SCI. In particular, an important component of SCI is the ischemia-reperfusion injury (IRI) that leads to endothelial dysfunction and changes in vascular permeability. Indeed, together with endothelial cell damage and failure in homeostasis, ischemia reperfusion injury triggers full-blown inflammatory cascades arising from activation of residential innate immune cells (microglia and astrocytes) and infiltrating leukocytes (neutrophils and macrophages). These inflammatory cells release neurotoxins (proinflammatory cytokines and chemokines, free radicals, excitotoxic amino acids, nitric oxide (NO)), all of which partake in axonal and neuronal deficit. Therefore, our review considers the recent advances in SCI mechanisms, whereby it becomes clear that SCI is a heterogeneous condition. Hence, this leads towards evidence of a restorative approach based on monotherapy with multiple targets or combinatorial treatment. Moreover, from evaluation of the existing literature, it appears that there is an urgent requirement for multi-centered, randomized trials for a large patient population. These clinical studies would offer an opportunity in stratifying SCI patients at high risk and selecting appropriate, optimal therapeutic regimens for personalized medicine.

Neuroinflammation and Modulation Role of Natural Products After Spinal Cord Injury

Inflammation & apoptosis in spinal cord injury.

Transplantation Strategies for Spinal Cord Injury Based on Microenvironment Modulation

Role of inflammation in neurological damage and regeneration following spinal cord injury and its therapeutic implications

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Modulating neuroinflammation through molecular, cellular and biomaterial‐based approaches to treat spinal cord injury

Inflammatory Response to Spinal Cord Injury and Its Treatment

Effects of astrocytes and microglia on neuroinflammation after spinal cord injury and related immunomodulatory strategies

Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar

Microenvironments‐Modulated Biomaterials Enhance Spinal Cord Injury Therapy

Epigenetic modifications of inflammation in spinal cord injury

Inflammogenesis of Secondary Spinal Cord Injury

Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration

Spinal cord injury: molecular mechanisms and therapeutic interventions

Multiple Mechanisms of Curcumin Targeting Spinal Cord Injury

Research Advances of Biomaterials-Based Microenvironment-Regulation Therapies for Repair and Regeneration of Spinal Cord Injury

Therapeutic Effects of Traditional Chinese Medicine on Spinal Cord Injury: A Promising Supplementary Treatment in Future.

Modulatory effects of gut microbiota on innate and adaptive immune responses following spinal cord injury

Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury

Biomaterial-based regenerative therapeutic strategies for spinal cord injury